A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
NCT ID: NCT04056026
Last Updated: 2019-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
1 participants
INTERVENTIONAL
2018-09-18
2018-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
NCT05273255
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364
Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NCT04721041
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1
NCT04130763
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fecal Microbiota Transplant
The patient will undergo fecal microbiota transplant. The 600cc of donor stool will be transplanted by colonoscopy.
Fecal Microbiota Transplant
Fecal material from a healthy family donor will be transplanted into the patient via colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fecal Microbiota Transplant
Fecal material from a healthy family donor will be transplanted into the patient via colonoscopy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient deemed not a candidate for PD-1 Blockade inhibitor therapy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ProgenaBiome
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ProgenaBiome
Ventura, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ProgenaBiome-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.